Amgen’s novel lung cancer drug disappoints in phase III
April 1, 2011Research and Development Amgen, Millennium, NSCLC, Takeda, motesanib, non-small cell lung cancer
Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …
GSK details $28.5m of research payments to US institutions
April 1, 2011Research and Development GSK, payments
GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …
TcL Pharma appoints French pharma veterans
April 1, 2011Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment
TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …
NHS reforms caught in a ‘reality gap’ as dissent grows
March 31, 2011Andrew Lansley, Liberating the NHS, NHS, NHS reform
The proposed NHS reforms are in danger of failing because of a ‘reality gap’ between the government’s ambitions for change …
AstraZeneca pays $1.1bn to resolve tax affairs
March 31, 2011Sales and Marketing AstraZeneca, tax
AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …
Valeant makes $5.7 billion hostile bid for Cephalon
March 31, 2011Research and Development, Sales and Marketing Cephalon, Valeant
Valeant has made a hostile bid for Cephalon, but analysts believe its offer is too low for the deal to …
Roche appoints Janet Hammond to translational medicine role
March 31, 2011Research and Development appointment, research and development
Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …
AZ’s Dr Yunxia Bi joins ISP
March 30, 2011Manufacturing and Production appointment, manufacturing and production
ISP Pharmaceuticals has appointed Dr Yunxia (Vivian) Bi as technical director of its solubility initiative. It is a newly-created position …
Merck re-submits Erbitux to the EMA for lung cancer
March 30, 2011Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer
Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …
Milburn adds his voice to growing disquiet on NHS reforms
March 30, 2011Alan Milburn, NHS, NHS reforms
Former Labour health secretary Alan Milburn has come out against the government’s health reforms, adding to the chorus of voices …
NHS Alliance: Social enterprises are future of public health services
March 30, 2011NHS, NHS Alliance, NHS reforms, Right to Request, public health services, social enterprise
The NHS Alliance has once more backed the idea that social enterprise should form the backbone of public health services …
New pharma skills needed for GP commissioning changes
March 30, 2011Business Services, Sales and Marketing NHS reforms, skills, training
With GP-led commissioning taking the NHS into new territory, market access is facing a major shake up. In January, one …
Dr Clive Deverson joins Photosound
March 30, 2011Medical Communications appointment, medical communications
Photosound has appointed Dr Clive Deverson as head of client strategy and medical communications. He joins the Hertfordshire, UK-based global …
EU Clinical Trials Register is Launched
March 29, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
The European Medicines Agency (EMA) has announced the launch of its EU Clinical Trials Register. This online register allows public …
Roche changes raise Novartis takeover question
March 29, 2011Sales and Marketing Novartis, Roche, mergers and acquisitions
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom. The Roche family …
Chiltern Expands European Operations with a New Office in The Netherlands
March 29, 2011Research and Development
Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in …
FDA issues guidance on glass contamination
March 29, 2011Manufacturing and Production FDA, GMP, glass contamination
The FDA has issued an advisory to pharmaceutical manufacturers on the topic of contamination with thin glass fragments – or …
Contract research news in brief
March 28, 2011Manufacturing and Production Almac, Aptiv Solutions, Cosmic Discoveries, InhibOx, Quintiles
Contract research organisation Quintiles Transnational has pulled back from plans to seek $2.4 billion in financing, saying that conditions in …
Gerresheimer buys Vedat to get bigger in South America
March 28, 2011Manufacturing and Production Brazil, Gerresheimer, packaging
Glass and plastics packaging specialist Gerresheimer has acquired Brazilian company Vedat in a major push into the South American pharmaceutical …
IDT Biologika expands investment in German manufacturing capacity
March 28, 2011Manufacturing and Production Germany, IDT Biologika, vaccines
IDT Biologika has said it plans to invest around 85 million euros in new production facilities and equipment in Germany …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
